Kailera Therapeutics, Inc. (KLRA) Ownership - Who Owns Kailera Therapeutics, Inc.?

Q: What percentage of Kailera Therapeutics, Inc. (KLRA) stock is held by retail investors?

According to the latest TipRanks data, approximately 12.47% of Kailera Therapeutics, Inc. (KLRA) stock is held by retail investors.

Q: Who owns the most shares of Kailera Therapeutics, Inc. (KLRA)?

Bain Capital Investors Llc owns the most shares of Kailera Therapeutics, Inc. (KLRA).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

31 Followers

Kailera Therapeutics, Inc. (KLRA) Ownership Overview

85.31% Insiders

<0.01% Mutual Funds

2.22% ETFs

12.47% Public Companies and

Individual Investors

The ownership structure of Kailera Therapeutics, Inc. (KLRA) stock is a mix of institutional, retail, and individual investors. , 85.31% is owned by Insiders, and 12.47% is owned by Public Companies and Individual Investors.

The ownership structure of Kailera Therapeutics, Inc. (KLRA) stock is a mix of institutional, retail, and individual investors. Approximately 2.23% of the company’s stock is owned by Institutional Investors, 85.31% is owned by Insiders, and 12.47% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Apr 22, 2026	Rtw Investments, Lp	xxxxxxxxxxxxx	$8000000
Apr 20, 2026	Bain Capital Investors Llc	xxxxxxxxxxxxx	$134375008
Apr 20, 2026	Adam Koppel	xxxxxxxxxxxxx	$25000000
Apr 20, 2026	Bain Capital Life Sciences Investors, Llc	xxxxxxxxxxxxx	$25000000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
26,255,581	Insider	20.26%	522,486,062
26,255,581	Insider	20.26%	522,486,062
22,583,268	Insider	17.43%	449,407,033
22,583,268	Insider	17.43%	449,407,033
10,776,820	Insider	8.32%	214,458,718
2,644,153	Institution	2.04%	52,618,645
2,034,134	Insider	1.57%	40,479,267
129,280	Institution	0.10%	2,572,672
100,047	Institution	0.08%	1,990,935
38,094	Insider	0.03%	758,071

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	10,837	Institution	<0.01%	215,656

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,180,411	Institution	0.91%	27,078,628
Vanguard Small-Cap ETF	853,185	Institution	0.66%	19,572,064
Vanguard Small Cap Value ETF	275,016	Institution	0.21%	6,308,867
Vanguard Small-Cap Growth ETF	239,860	Institution	0.19%	5,502,388
ALPS Medical Breakthroughs ETF	129,280	Institution	0.10%	2,957,926
Roundhill GLP-1 & Weight Loss ETF	100,047	Institution	0.08%	1,990,935
Vanguard Extended Market ETF	59,388	Institution	0.05%	1,362,361
iShares Core S&P Total U.S. Stock Market ETF	46,176	Institution	0.04%	1,056,507
Vanguard Russell 2000 ETF	31,617	Institution	0.02%	725,294
Vanguard Russell 2000 Growth ETF	3,090	Institution	<0.01%	70,885

FAQ

Who Owns Kailera Therapeutics, Inc. (KLRA)?

Currently, no data Available

What percentage of Kailera Therapeutics, Inc. (KLRA) stock is held by institutional investors?

Currently, no data Available

What percentage of Kailera Therapeutics, Inc. (KLRA) stock is held by retail investors?

According to the latest TipRanks data, approximately 12.47% of Kailera Therapeutics, Inc. (KLRA) stock is held by retail investors.

Who owns the most shares of Kailera Therapeutics, Inc. (KLRA)?

Bain Capital Investors Llc owns the most shares of Kailera Therapeutics, Inc. (KLRA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.